pubmed-article:9848855 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C0038525 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C0678812 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C0265110 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C0023866 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C1552617 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C0282443 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
pubmed-article:9848855 | lifeskim:mentions | umls-concept:C2350691 | lld:lifeskim |
pubmed-article:9848855 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:9848855 | pubmed:dateCreated | 1999-3-12 | lld:pubmed |
pubmed-article:9848855 | pubmed:abstractText | Increasing evidence implicates endothelin (ET)-1 in the pathophysiological development of cerebral vasospasm. This study examined the ability of TBC 11251 (TBC), a new ETA receptor antagonist, to prevent vasospasm in a rabbit model of subarachnoid hemorrhage (SAH). | lld:pubmed |
pubmed-article:9848855 | pubmed:language | eng | lld:pubmed |
pubmed-article:9848855 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9848855 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9848855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9848855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9848855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9848855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9848855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9848855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9848855 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9848855 | pubmed:month | Dec | lld:pubmed |
pubmed-article:9848855 | pubmed:issn | 0148-396X | lld:pubmed |
pubmed-article:9848855 | pubmed:author | pubmed-author:LeeK SKS | lld:pubmed |
pubmed-article:9848855 | pubmed:author | pubmed-author:WestKK | lld:pubmed |
pubmed-article:9848855 | pubmed:author | pubmed-author:KassellN FNF | lld:pubmed |
pubmed-article:9848855 | pubmed:author | pubmed-author:HelmG AGA | lld:pubmed |
pubmed-article:9848855 | pubmed:author | pubmed-author:ArthurA SAS | lld:pubmed |
pubmed-article:9848855 | pubmed:author | pubmed-author:WaneboJ EJE | lld:pubmed |
pubmed-article:9848855 | pubmed:author | pubmed-author:LouisH GHG | lld:pubmed |
pubmed-article:9848855 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9848855 | pubmed:volume | 43 | lld:pubmed |
pubmed-article:9848855 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9848855 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9848855 | pubmed:pagination | 1409-17; discussion 1417-8 | lld:pubmed |
pubmed-article:9848855 | pubmed:dateRevised | 2008-6-5 | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:meshHeading | pubmed-meshheading:9848855-... | lld:pubmed |
pubmed-article:9848855 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9848855 | pubmed:articleTitle | Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. | lld:pubmed |
pubmed-article:9848855 | pubmed:affiliation | Department of Neurosurgery, National Naval Medical Center, Bethesda, Maryland, USA. | lld:pubmed |
pubmed-article:9848855 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9848855 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:9848855 | pubmed:publicationType | Review | lld:pubmed |
pubmed-article:9848855 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9848855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9848855 | lld:pubmed |